SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in LENZ — LENZ Therapeutics, Inc.
CIK 1446194
BALA CYNWYD, PA
Position in LENZ
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,009,281
-$74,271 QoQ
Shares Held
110,304
+62.9% QoQ
Ownership
0.352%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LENZ Over Time
Shares Held
Position Value (USD)
Derivatives in LENZ
reported options exposure · as of Mar 31, 2026CallValue
$136,335
CallShares
14,900
PutValue
$1,227,930
PutShares
134,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,159,899,084 across 353 Biotechnology names. LENZ ranks #166 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
898,951 | $59,249,860 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
174,268 | $57,660,053 | |
| 3 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,344,953 | $45,499,759 | |
| 4 | ABVX |
Abivax S.A.
|
381,282 | $42,455,750 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
398,943 | $29,625,507 | |
| 6 | INSM |
INSMED Inc
|
173,630 | $28,391,977 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
593,406 | $28,228,323 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
521,571 | $27,497,223 |
All Filings in LENZ
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $136,335 | 14,900 | Call | Other | 2026-05-15 | |
| 2026-03-31 | $1,009,281 | 110,304 | Shares | Other | 2026-05-15 | |
| 2026-03-31 | $1,227,930 | 134,200 | Put | Other | 2026-05-15 | |
| 2025-12-31 | $1,964,800 | 122,800 | Put | Other | 2026-02-17 | |
| 2025-12-31 | $713,600 | 44,600 | Call | Other | 2026-02-17 | |
| 2025-12-31 | $1,083,552 | 67,722 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $2,354,665 | 50,551 | Shares | Other | 2025-11-14 | |
| 2025-09-30 | $4,630,052 | 99,400 | Put | Other | 2025-11-14 | |
| 2025-09-30 | $833,782 | 17,900 | Call | Other | 2025-11-14 | |
| 2025-06-30 | $5,114,595 | 174,500 | Call | Other | 2025-08-14 | |
| 2025-06-30 | $650,242 | 22,185 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $419,484 | 16,316 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $231,421 | 8,016 | Shares | Other | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||